We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare

243 hedge funds and large institutions have $2.42B invested in Prestige Consumer Healthcare in 2016 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 97 increasing their positions, 91 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 91

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.2% less ownership

Funds ownership: 100%98.8% (-1.2%)

10% less funds holding

Funds holding: 269243 (-26)

17% less capital invested

Capital invested by funds: $2.92B → $2.42B (-$501M)

52% less call options, than puts

Call options by funds: $1.05M | Put options by funds: $2.19M

54% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 48

Holders
243
Holders Change
-26
Holders Change %
-9.67%
% of All Funds
6.48%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
22
Increased
97
Reduced
91
Closed
48
Calls
$1.05M
Puts
$2.19M
Net Calls
-$1.14M
Net Calls Change
-$1.02M

PBH Hedge Fund Activity: Q3 2016 in Review

243 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2016, worth a combined $2.42B — down 17% from $2.92B a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of PBH and 22 opened new positions — a net loss of 26 holders — while 91 trimmed existing stakes and 97 added.

The largest buyer was VOYA Investment Management, adding an estimated $70.2M. The largest seller was Acadian Asset Management, cutting an estimated $52M.

  • 243 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2016, down from 269 in Q2 2016.
  • Funds reported $2.42B of Prestige Consumer Healthcare stock for Q3 2016, down 17% quarter-over-quarter.
  • 22 funds opened new Prestige Consumer Healthcare positions in Q3 2016 and 48 closed out, a net change of -26 holders.
  • The largest Prestige Consumer Healthcare buyer in Q3 2016 was VOYA Investment Management, an estimated $70.2M added.
  • The largest Prestige Consumer Healthcare seller in Q3 2016 was Acadian Asset Management, an estimated $52M sold.

Based on aggregated 13F filings for Q3 2016.